Skip to main content
Top
Published in: BMC Infectious Diseases 1/2019

Open Access 01-12-2019 | Nosocomial Infection | Research article

An investigation of Stenotrophomonas maltophilia-positive culture caused by fiberoptic bronchoscope contamination

Authors: Bende Liu, Shenglan Tong

Published in: BMC Infectious Diseases | Issue 1/2019

Login to get access

Abstract

Background

Stenotrophomonas maltophilia (SMA) is present in hospital environments and has been one of the pathogens that cause nosocomial contamination and infections. To investigate the occurrence of Stenotrophomonas maltophilia (SMA) in bronchoscope lavage fluid (BALF) among 25 cases treated in the Division of Infection and to trace the contamination source and transmission route.

Methods

25 cases of SMA positive BALF occurring from May 11 to August 10, 2018 were tested for drug sensitivity. Environmental hygiene conditions were investigated to identify the source of contamination and the route of transmission.

Results

BALF associated SMA was in all cases sensitive to minocycline, levofloxacin and chloramphenicol and resistant to ceftazidime and imipenem. 92.3% of samples were sensitivity to compound sulfamethoxazole. Investigation of environmental hygiene parameters revealed SMA growing on the inner wall of the fiberoptic bronchoscope as a likely source of contamination.

Conclusion

Incomplete cleaning and sterilization of the fiberoptic bronchoscope led to SMA nosocomial contamination. Strict sterilization procedures are required to prevent and control nosocomial contamination.
Literature
1.
go back to reference Paez JI, Costa SF. Risk factors associated with mortality of infections caused by Stenotrophomonas maltophilia: a systematic review. J Hosp Infect. 2008;70(2):101–8.CrossRef Paez JI, Costa SF. Risk factors associated with mortality of infections caused by Stenotrophomonas maltophilia: a systematic review. J Hosp Infect. 2008;70(2):101–8.CrossRef
2.
go back to reference Palleroni NJ, Bradbury JF. Stenotrophomonas, a new bacterial genus for Xanthomonas maltophilia (Hugh 1980) swings et al. 1983. Int J Syst Bacteriol. 1993;43(3):606–9.CrossRef Palleroni NJ, Bradbury JF. Stenotrophomonas, a new bacterial genus for Xanthomonas maltophilia (Hugh 1980) swings et al. 1983. Int J Syst Bacteriol. 1993;43(3):606–9.CrossRef
3.
go back to reference Betts JW, Phee LM, Woodford N, Wareham DW. Activity of colistin in combination with tigecycline or rifampicin against multidrug-resistant Stenotrophomonas maltophilia. Eur J Clin Microbiol Infect Dis Off Publ Eur Soc Clin Microbiol. 2014;33(9):1565–72.CrossRef Betts JW, Phee LM, Woodford N, Wareham DW. Activity of colistin in combination with tigecycline or rifampicin against multidrug-resistant Stenotrophomonas maltophilia. Eur J Clin Microbiol Infect Dis Off Publ Eur Soc Clin Microbiol. 2014;33(9):1565–72.CrossRef
4.
go back to reference Savini V, Catavitello C, D'Aloisio M, Balbinot A, Astolfi D, Masciarelli G, Pompilio A, Di Bonaventura G, D'Antonio D. Chloramphenicol and rifampin may be the only options against Stenotrophomonas maltophilia. A tale of a colonized bladder device in a patient with myelofibrosis. Infez Med. 2010;18(3):193–7.PubMed Savini V, Catavitello C, D'Aloisio M, Balbinot A, Astolfi D, Masciarelli G, Pompilio A, Di Bonaventura G, D'Antonio D. Chloramphenicol and rifampin may be the only options against Stenotrophomonas maltophilia. A tale of a colonized bladder device in a patient with myelofibrosis. Infez Med. 2010;18(3):193–7.PubMed
5.
go back to reference Beltran Silva S, Cervantes Apolinar Y, Cherry JD, Conde Gonzalez C, Gentile A, Gomez Altamirano CM, Hernandez Porras M, Huerta Garcia G, Macias Parra M, Martinez Aguilar G, et al. Consensus on the clinical and microbiologic diagnosis of Bordetella pertussis, and infection prevention. Expert group on pertussis vaccination. Salud publica de Mex. 2011;53(1):57–65.CrossRef Beltran Silva S, Cervantes Apolinar Y, Cherry JD, Conde Gonzalez C, Gentile A, Gomez Altamirano CM, Hernandez Porras M, Huerta Garcia G, Macias Parra M, Martinez Aguilar G, et al. Consensus on the clinical and microbiologic diagnosis of Bordetella pertussis, and infection prevention. Expert group on pertussis vaccination. Salud publica de Mex. 2011;53(1):57–65.CrossRef
6.
go back to reference Gupta P, Kale P, Khillan V. Resurgence of global opportunistic multidrug-resistant Stenotrophomonas maltophilia. Indian J Crit Care Med. 2018;22(7):503–8.CrossRef Gupta P, Kale P, Khillan V. Resurgence of global opportunistic multidrug-resistant Stenotrophomonas maltophilia. Indian J Crit Care Med. 2018;22(7):503–8.CrossRef
7.
go back to reference Giamarellos-Bourboulis EJ, Karnesis L, Giamarellou H. Synergy of colistin with rifampin and trimethoprim/sulfamethoxazole on multidrug-resistant Stenotrophomonas maltophilia. Diagn Microbiol Infect Dis. 2002;44(3):259–63.CrossRef Giamarellos-Bourboulis EJ, Karnesis L, Giamarellou H. Synergy of colistin with rifampin and trimethoprim/sulfamethoxazole on multidrug-resistant Stenotrophomonas maltophilia. Diagn Microbiol Infect Dis. 2002;44(3):259–63.CrossRef
8.
go back to reference Drapeau CM, Grilli E, Petrosillo N. Rifampicin combined regimens for gram-negative infections: data from the literature. Int J Antimicrob Agents. 2010;35(1):39–44.CrossRef Drapeau CM, Grilli E, Petrosillo N. Rifampicin combined regimens for gram-negative infections: data from the literature. Int J Antimicrob Agents. 2010;35(1):39–44.CrossRef
9.
go back to reference Passerini de Rossi B, Calenda M, Vay C, Franco M. Biofilm formation by Stenotrophomonas maltophilia isolates from device-associated nosocomial infections. Rev Argent Microbiol. 2007;39(4):204–12.PubMed Passerini de Rossi B, Calenda M, Vay C, Franco M. Biofilm formation by Stenotrophomonas maltophilia isolates from device-associated nosocomial infections. Rev Argent Microbiol. 2007;39(4):204–12.PubMed
10.
go back to reference Biocanin M, Madi H, Vasiljevic Z, Kojic M, Jovcic B, Lozo J. Temperature, pH and trimethoprim-Sulfamethoxazole are potent inhibitors of biofilm formation by Stenotrophomonas maltophilia clinical isolates. Pol J Microbiol. 2017;66(4):433–8.CrossRef Biocanin M, Madi H, Vasiljevic Z, Kojic M, Jovcic B, Lozo J. Temperature, pH and trimethoprim-Sulfamethoxazole are potent inhibitors of biofilm formation by Stenotrophomonas maltophilia clinical isolates. Pol J Microbiol. 2017;66(4):433–8.CrossRef
Metadata
Title
An investigation of Stenotrophomonas maltophilia-positive culture caused by fiberoptic bronchoscope contamination
Authors
Bende Liu
Shenglan Tong
Publication date
01-12-2019
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2019
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-019-4670-3

Other articles of this Issue 1/2019

BMC Infectious Diseases 1/2019 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.